Genentech, the National Institute of Health (NIH) and the Banner Alzheimer’s Institute have partnered to carry out the first-ever study of healthy individuals. In this study, 300 members of distantly related families in Colombia who share a rare gene mutation that triggers Alzheimer’s disease (AD) in early life, with initial symptoms appearing around the age of 45. A small number of US citizens will also be included in this study.
This study is the first of its kind, in that it will examine patients before they show any symptoms of cognitive decline. Continue reading →
The US government has stepped up the battle against Alzheimer’s disease by helping to launch a $100m clinical study on a promising new drug, crenezumab, that doctors hope will help against the debilitating condition. The National Institutes of Health is actively involved, helping Genentech and the Banner Alzheimer’s Institute to fund the research. Continue reading →